personalised mRNA vaccine | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21,949 results for “personalised mRNA vaccine”

Trials

View all 12734 →

A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

30 participants · First posted Jan 20, 2022

Not yet recruiting

Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation

67 participants · First posted Mar 9, 2023

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery

9 participants · First posted Jun 30, 2026

Drugs

View all 5764 →

SW-1115-C3

mRNA vaccine

Conditions: COVID-19

mRNA RSV vaccine

Organizations

View all 90 →

AIM VACCINE

China

Finlay Vaccine Institute

Path Vaccine Solutions

United States

News

View all 3361 →

Community Rallies to Fund Personalised mRNA Vaccine for Three-Year-Old Australian Girl with DIPG

NHS Launches Personalised Cancer Vaccine Program Across England with Thousands Expected to Enroll

Oxford and Manchester Secure Major UK Funding for AI-Driven Personalised Cancer Vaccines and Immunotherapy Research

Page 1 of 2195